Shree Ganesh Biotech Share Price Target Tomorrow, 2025, 2030, 2035, 2040: Shree Ganesh Biotech is an emerging Indian company engaged in the agricultural and biotechnology sectors. The company focuses on providing high-quality seeds, fertilizers, and other agricultural products to enhance productivity and sustainability in farming.
As of February 1, 2025, the Shree Ganesh Biotech share price on the NSE is ₹0.98. Below are the projected Shree Ganesh Biotech share price target for the years, 2025, 2026, 2027, 2030, 2035 And 2040.
Additionally, feel free to join our – Tele-(g)ram) where we share Fast stock market news and updates➥https://bit.ly/TradeWatch360
Shree Ganesh Biotech Company Overview
Shree Ganesh Biotech is a company based in Kolkata, India. It focuses on helping farmers grow better crops using biotechnology. The company makes and sells hybrid seeds, organic fertilizers, and plant growth boosters. Their goal is to support eco-friendly farming and improve crop production. Shree Ganesh Biotech also works on new ideas to create better farming products for the future.
Trade name | Shree Ganesh Biotech |
Company type | Public |
Traded as | BSE: 539470 |
ISIN | INE051N01026 |
Industry | Health care |
Founded | 1982; 42 years ago |
Founders | Mr. Shankar Kumar Choudhary Mr. Prashant Kumar Choudhary |
Headquarters | Kolkata, West Bengal, India |
Area served | Primarily India |
Key People | Aman Patel (Chairman & CO) Kishan Nityanand Naidu (CFO) Nimeshkumar Mohanbhai Parmar (Director) Amrutaben Rajanbhai Solanki (Director) |
Revenue | ₹13.44 crore(US$19 billion) (2024) |
Operating income | ₹-0.54 crore(US$4.3 billion) (2024) |
Net income | ₹1.19 crore(US$3.1 billion) (2024) |
Total assets | ₹63.66 crore(US$17 billion) (2024) |
Website | www.shreeganeshbiotech.com |
One Year Shree Ganesh BioTech India Share Price Growth Chart

Shree Ganesh Biotech Share Price Target
Now let us talk about the main point, Shree Ganesh Biotech Share Price Target. We predict share price through a combination of fundamental and technical analysis of the company’s stock. Through our extensive experience and our team’s in-depth research, we aim to provide a clear forecast of the potential direction in which the share price might move in the future as follows:
Shree Ganesh Biotech Share Price Target For 2025
By 2025, Shree Ganesh Biotech’s share price might reach ₹1.7 first and then ₹2.0. The company is growing in farming and science, creating new ideas to help it grow and become more valuable.
Year | 1st Target | 2nd Target |
2025 | 1.7 | 2.0 |
Read More:- PC Jeweller Share Price Target Tomorrow, 2025, 2030, 2035, and 2040
Shree Ganesh Biotech Stock Price Target For 2026
By 2026, the stock price of Shree Ganesh Biotech is expected to go up. The first target is ₹2.8, and the second target is ₹3.5. This growth is because the company is improving its technology, and more people are using its biotech products.
Year | 1st Target | 2nd Target |
2026 | 2.8 | 3.5 |
Shree Ganesh Biotech Share Price Forecast For 2027
In 2027, Shree Ganesh Biotech is projected to reach a share price of ₹4.3 as the first target and ₹5.0 as the second target. Its consistent emphasis on research, innovation, and meeting market demands positions it for sustained growth.
Year | 1st Target | 2nd Target |
2027 | 4.3 | 5.0 |
Shree Ganesh Biotech Stock Price Forecast For 2028
By 2028, the company’s stock price is expected to reach ₹5.8 first and then ₹6.6. More people want eco-friendly and high-quality biotech products, which may help the company grow.
Year | 1st Target | 2nd Target |
2028 | 5.8 | 6.6 |
Shree Ganesh Biotech Share Price Prediction For 2029
By 2029, Shree Ganesh Biotech is expected to see its share price climb to ₹7.2 as the first target and ₹8.3 as the second target. The company innovation-driven growth and strong supply chain will likely contribute to its increasing market value.
Year | 1st Target | 2nd Target |
2029 | 7.2 | 8.3 |
Shree Ganesh Biotech Stock Price Prediction For 2030
In 2030, Shree Ganesh Biotech is anticipated to reach stock price targets of ₹9.2 as the first target and ₹10.5 as the second target. Its focus on global expansion and sustainable practices will drive long-term success.
Year | 1st Target | 2nd Target |
2030 | 9.2 | 10.5 |
Shree Ganesh Biotech Share Price Target For 2035
By 2035, the share price of Shree Ganesh Biotech is projected to touch ₹16.0 as the first target and ₹20.0 as the second target. Its leadership in biotechnology solutions and ability to meet global demands will likely position it as a key player in the industry.
Year | 1st Target | 2nd Target |
2035 | 16.0 | 20.0 |
Read More:- Tunwal E-Motors Share Price Target Tomorrow, 2025, 2030, 2035, and 2040
Shree Ganesh Biotech Stock Price Target For 2040
By the year 2040, Shree Ganesh Biotech’s stock price might reach ₹28 first and then ₹35. The company is working hard on new ideas and growing bigger, which will help it become a top biotech company in the world.
Year | 1st Target | 2nd Target |
2040 | 28.0 | 35.0 |
Shree Ganesh Biotech Share Price Target From 2025 To 2040
Year | Year High Target (₹) | Year Low Target (₹) |
2025 | 2.0 | 0.8 |
2026 | 3.5 | 1.2 |
2027 | 5.0 | 2.1 |
2028 | 6.6 | 3.4 |
2029 | 8.3 | 5.1 |
2030 | 10.5 | 6.8 |
2035 | 20.0 | 8.5 |
2040 | 35.0 | 13.0 |
Shree Ganesh Biotech Limited Peers comparison
Sector: Pharmaceuticals | Industry: Pharmaceuticals – Indian – Bulk Drugs & Formln | ||||
Name | P/E | Mar Cap ₹Cr. | Div Yld% | NP Qtr ₹Cr. | ROCE% |
Sun Pharma.Inds. | 39.60 | 443792 | 0.73 | 3037 | 17.32 |
Cipla | 26.50 | 122050 | 0.86 | 1305 | 22.80 |
MankindPharma | 60.47 | 121193 | 0.00 | 634 | 24.57 |
Dr Reddy’s Labs | 21.14 | 112868 | 0.59 | 1341 | 26.53 |
Lupin | 41.15 | 108075 | 0.34 | 859 | 15.72 |
Zydus Lifesci. | 22.95 | 98188 | 0.31 | 920 | 22.34 |
Aurobindo Pharma | 21.21 | 77311 | 0.34 | 816 | 14.10 |
Shree Ganesh Bio | 34.84 | 41 | 0.00 | 0.32 | 1.37 |
Shree Ganesh Biotech Limited Fundamentals
Parameter | Value |
Market Cap | ₹41 Cr |
P/E Ratio (TTM) | 34.67 |
P/B Ratio | 0.65 |
Industry P/E | 49.05 |
Debt to Equity | 0.00 |
ROE | 1.88% |
EPS (TTM) | 0.03 |
Dividend Yield | 0.00% |
52 Week High | ₹1.70 |
52 Week Low | ₹0.94 |
Book Value | 1.59 |
Face Value | 1 |
Shree Ganesh Biotech Limited Financial Results
All in ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
Sales | 17.21 | 72.64 | 62.45 | 20.28 | 13.44 |
Expenses | 16.50 | 69.19 | 60.30 | 20.48 | 13.98 |
Operating Profit | 0.71 | 3.45 | 2.15 | -0.20 | -0.54 |
OPM % | 4.13% | 4.75% | 3.44% | -0.99% | -4.02% |
Other Income | -0.28 | 0.05 | 0.56 | 1.06 | 1.73 |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax | 0.43 | 3.50 | 2.71 | 0.86 | 1.19 |
Tax % | 25.58% | 27.71% | 25.09% | 26.74% | |
Net Profit | 0.32 | 2.53 | 2.04 | 0.62 | 1.19 |
EPS in Rs | 0.01 | 0.06 | 0.05 | 0.02 | 0.03 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
Shree Ganesh Biotech Limited Balance Sheet
All in ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
Equity Capital | 19.93 | 19.93 | 39.86 | 39.86 | 39.86 |
Reserves | 37.86 | 40.39 | 22.49 | 23.12 | 23.68 |
Borrowings | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Liabilities | 16.64 | 33.24 | 17.18 | 10.64 | 0.12 |
Total Liabilities | 74.62 | 93.56 | 79.53 | 73.62 | 63.66 |
Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 3.06 | 3.22 | 0.00 | 0.00 | 0.00 |
Other Assets | 71.56 | 90.34 | 79.53 | 73.62 | 63.66 |
Total Assets | 74.62 | 93.56 | 79.53 | 73.62 | 63.66 |
Shree Ganesh Biotech Limited Shareholding Pattern

FAQs
Q.1. What is the target price of Shree Ganesh Biotech in 2025?
Ans: In 2025, Shree Ganesh Biotech is set to capitalize on the growing demand for its advanced engineering and transmission solutions across industries. The share price is expected to reach ₹1.7 as the first target and ₹2.0 as the second target.
Q.2. What is the Shree Ganesh Biotech Share Price Forecast For 2026?
Ans: By 2026, Shree Ganesh Biotech is projected to benefit from technological advancements and increased adoption of efficient machinery in key industries. The share price is anticipated to hit ₹2.8 as the first target and ₹3.5 as the second target.
Q.3. What is the Shree Ganesh Biotech Share Price Target For 2027?
Ans: In 2027, Shree Ganesh Biotech focused on innovation and its ability to meet evolving customer needs could push the share price to ₹4.3 as the first target and ₹5.0 as the second target.
Q.4. What is the Shree Ganesh Biotech Share Price Target For 2028?
Ans: By 2028, Shree Ganesh Biotech is expected to further strengthen its position in the engineering and manufacturing sectors. The share price is forecasted to reach ₹5.8 as the first target and ₹6.6 as the second target.
Q.5. What is the Shree Ganesh Biotech Share Price Target For 2029?
Ans: In 2029, Shree Ganesh Biotech is projected to see significant growth driven by its innovative solutions and efficient supply chain management. The share price is estimated to touch ₹7.2 as the first target and ₹8.3 as the second target.
Q.6. What is the Shree Ganesh Biotech Share Price Target For 2030?
Ans: By 2030, Shree Ganesh Biotech focus on research and development, along with strategic global expansions, could propel its share price to ₹9.2 as the first target and ₹10.5 as the second target.
Q.7. What is the Shree Ganesh Biotech Share Price Target For 2035?
Ans: By 2035, Shree Ganesh Biotech is anticipated to emerge as a leader in the transmission systems and components industry. The share price is forecasted to reach ₹16.0 as the first target and ₹20.0 as the second target.
Q.8. What is the Shree Ganesh Biotech Stock Price Target For 2040?
Ans: Looking ahead to 2040, Shree Ganesh Biotech continued investments in innovation and market expansion could see its share price soar to ₹28.0 as the first target and ₹35.0 as the second target.
Q.10. Who is the CEO of Shree Ganesh Biotech India?
Ans: The company leadership includes Mr. Aman Patel, who serves as the Whole-time Director, Chairman, and Compliance Officer since March 21, 2020.
Q.11. Is Shree Ganesh Biotech a Good Buy for the Long Term?
Ans: Shree Ganesh Biotech could be a good long-term investment if it shows consistent growth, profitability, and market demand for its products like tissue culture and hybrid seeds. Investors should analyze its financials, innovation potential, and industry position before deciding.
Q.12. Is Shree Ganesh Biotech Debt-Free?
Ans: To confirm if Shree Ganesh Biotech is debt-free, review its latest financial statements. Being debt-free would indicate financial stability, but verifying through reliable sources is essential.

TradeWatch360 is a premier platform dedicated to providing real-time insights, trends, and updates in the stock market. It is designed to support both new and seasoned investors by delivering timely and actionable information across a range of asset classes, including stocks, futures, commodities, and global markets.